Ginkgo Bioworks Holdings, Inc. files 10-Q

Ginkgo Bioworks Holdings, Inc. reported a net loss of $82.6 million for the quarter ended March 31, 2026, a decrease from the $90.9 million net loss in the same period last year, driven by lower revenue and reduced operating expenses. The company completed the sale of its Biosecurity business and has $143.9 million in cash and cash equivalents.